Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin S Weber

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|March 24, 2015
Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?Martin S Weber
Expert Opinion on Investigational Drugs|August 11, 2020
Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosisSebastian Torke, Martin S Weber
International Journal of Molecular Sciences|January 11, 2019
Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is EnoughDarius Häusler, Martin S Weber
Current Opinion in Neurology|March 30, 2021
Targeting B cells in multiple sclerosisFinn Sellebjerg, Martin S Weber
CNS Drugs|November 16, 2016
B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical EvidenceSilke Kinzel, Martin S Weber
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Towards Treating Multiple Sclerosis ProgressionDarius Häusler, Martin S Weber
Brain Sciences|June 23, 2017
The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS DemyelinationSilke Kinzel, Martin S Weber
Results and Problems in Cell Differentiation|July 8, 2009
Cooperation of B cells and T cells in the pathogenesis of multiple sclerosisMartin S Weber, Bernhard Hemmer
Frontiers in Immunology|February 26, 2019
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related DisordersSilke Häusser-Kinzel, Martin S Weber
JAMA Neurology|June 19, 2018
Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Central Nervous System Demyelination-A Novel Disease Entity?Martin S Weber, Tobias Derfuss, Wolfgang Brück
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Neurology(R) Neuroimmunology & Neuroinflammation|March 24, 2015
Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?Martin S Weber
Expert Opinion on Investigational Drugs|August 11, 2020
Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosisSebastian Torke, Martin S Weber
International Journal of Molecular Sciences|January 11, 2019
Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is EnoughDarius Häusler, Martin S Weber
Current Opinion in Neurology|March 30, 2021
Targeting B cells in multiple sclerosisFinn Sellebjerg, Martin S Weber
CNS Drugs|November 16, 2016
B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical EvidenceSilke Kinzel, Martin S Weber
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Towards Treating Multiple Sclerosis ProgressionDarius Häusler, Martin S Weber
Brain Sciences|June 23, 2017
The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS DemyelinationSilke Kinzel, Martin S Weber
Results and Problems in Cell Differentiation|July 8, 2009
Cooperation of B cells and T cells in the pathogenesis of multiple sclerosisMartin S Weber, Bernhard Hemmer
Frontiers in Immunology|February 26, 2019
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related DisordersSilke Häusser-Kinzel, Martin S Weber
JAMA Neurology|June 19, 2018
Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Central Nervous System Demyelination-A Novel Disease Entity?Martin S Weber, Tobias Derfuss, Wolfgang Brück
Pageof 14